SCHEMBL5956628

SCHEMBL5956628

COC(=O)c1cc2c(cc1Cl)C(N)CCS2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
GAA P10253 2/20 0.37
ABL1 P00519 1/20 0.35
SLC6A3 Q01959 2/20 0.34
USP2 O75604 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SERPINH1 P50454 1/20 0.33
PSMD14 O00487 1/20 0.33
PLA2G1B P04054 1/20 0.33
ALPL P05186 1/20 0.33
POLB P06746 1/20 0.33
MMP2 P08253 1/20 0.33
ALPI P09923 1/20 0.33
ALPG P10696 1/20 0.33
PTPN7 P35236 1/20 0.33
DUSP3 P51452 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5956889 1.00 KMT2A (0.38) KMT2AMEN1GAAABL1SLC6A3
SCHEMBL5956637 0.85 MEN1 (0.38) KMT2AMEN1GAAABL1SLC6A3
SCHEMBL5956504 0.85 MEN1 (0.41) KMT2AMEN1GAASLC6A3MAPT
SCHEMBL5956730 0.85 MEN1 (0.41) KMT2AMEN1GAASLC6A3MAPT
SCHEMBL5956824 0.85 MEN1 (0.38) KMT2AMEN1GAAABL1SLC6A3
SCHEMBL5956457 0.84 GAA (0.43) KMT2AMEN1GAASMN1; SMN2POLB
SCHEMBL5956469 0.84 GAA (0.43) KMT2AMEN1GAASMN1; SMN2POLB
SCHEMBL5956821 0.77 KMT2A (0.40) KMT2AMEN1GAAUSP2PSMD14
SCHEMBL5956635 0.77 KMT2A (0.40) KMT2AMEN1GAAUSP2PSMD14
SCHEMBL5956819 0.76 MEN1 (0.50) KMT2AMEN1GAASLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1270570-B1 AMIDE COMPOUNDS AND USE THEREOF MITSUBISHI PHARMA CORP (JP) 2006-05-31 EP disclosed
US-6933305-B2 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2005-08-23 US disclosed
US-20030158413-A1 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2003-08-21 US disclosed
EP-1270570-A1 AMIDE COMPOUNDS AND USE THEREOF Mitsubishi Pharma Corporation (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158413-A1 Amide compounds and use thereof ROCK2, ROCK1, RHOT2 KMT2A 1253/4885MEN1 2543/4885GAA 1515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.